UHRF1 and acute lymphoblastic leukemia: We employed virtual compound library screening to identify the inhibitor UM164 that targets UHRF1, which has been validated through in vitro experiments to induce apoptosis, suppress proliferation, and induce cell cycle arrest in B-ALL cells.